From Alpert Medical School, Brown University, Providence, RI.
J Am Board Fam Med. 2018 Nov-Dec;31(6):881-896. doi: 10.3122/jabfm.2018.06.180152.
As the opioid epidemic progresses, a better understanding of those at elevated risk of opioid overdose is needed, particularly for populations whose growing risk may be overlooked. Medicare recipients under age 65 (Medicare-disability beneficiaries [MDBs]) are one such population. We sought to analyze characteristics of opioid-overdose hospitalizations among MDBs and quantify the contribution of this population to opioid-overdose hospitalizations overall.
This retrospective cohort study included patients hospitalized for opioid overdose in the National/Nationwide Inpatient Sample from 1998 to 2013. The primary outcome measurements were number and characteristics of discharges, including patient sex, age, race, prescription opioid versus heroin overdose, and comorbidities.
MDBs constituted 11.7% of US opioid overdose hospitalizations among those under 65 years of age in 1998; this proportion grew to 24.5% by 2013 ( < .0001). The proportion of female patients grew markedly among this cohort ( < .0001) and were disproportionately represented among MDBs ( < .0001). Prescription opioid overdose accounted for a larger proportion of opioid overdose hospitalizations among MDBs than among non-Medicare-insured patients under 65 years old ( < .0001). MDBs generally exhibited greater comorbidity burden versus non-Medicare-insured patients under age 65; however, chronic drug and alcohol abuse were less commonly documented among the Medicare cohort ( < .0001).
MDBs constitute a substantial and growing proportion of opioid overdose hospitalizations in the United. To prevent opioid overdoses among MDBs, care must be taken to address the unique needs of this population.
随着阿片类药物流行的发展,需要更好地了解那些处于阿片类药物过量风险升高的人群,特别是对于那些风险不断增加但可能被忽视的人群。65 岁以下的医疗保险受助人(医疗保险残疾受益人 [MDB])就是这样一个人群。我们旨在分析 MDB 中阿片类药物过量住院的特征,并量化该人群对总体阿片类药物过量住院的贡献。
这项回顾性队列研究纳入了 1998 年至 2013 年期间因阿片类药物过量住院的全国/全国住院患者样本。主要的结果测量包括出院人数和特征,包括患者性别、年龄、种族、处方阿片类药物与海洛因过量以及合并症。
1998 年,MDB 占 65 岁以下阿片类药物过量住院患者的 11.7%;到 2013 年,这一比例增长到 24.5%(<0.0001)。该队列中女性患者的比例显著增加(<0.0001),且在 MDB 中不成比例地代表(<0.0001)。与 65 岁以下非医疗保险患者相比,MDB 中阿片类药物过量住院的处方阿片类药物过量比例更大(<0.0001)。MDB 一般比 65 岁以下非医疗保险患者表现出更大的合并症负担;然而,慢性药物和酒精滥用在医疗保险患者中记录较少(<0.0001)。
MDB 构成了美国阿片类药物过量住院的一个重要且不断增长的比例。为了预防 MDB 中的阿片类药物过量,必须注意解决这一人群的独特需求。